Diagnostic pathology of lymphoproliterative disorders

David W. Ellis*, Michael Eaton, Richard M. Fox, Surender Juneja, Anthony S Y Leong, John Miliauskas, Debra L. Norris, Dominic Spagnolo, Jenny Turner

*Corresponding author for this work

Research output: Contribution to journalReview article

11 Citations (Scopus)


The last 20 years have seen a dramatic change in the way we classify, and therefore diagnose, lymphoma. Two decades ago, the International Working Formulation enabled diagnosis and management on the basis of H&E sections alone, with no mandatory requirement for immunophenotyping, molecular studies or any other ancillary investigations. The concept of categorisation by 'clinicopathological entities' defined by clinical features, morphology, immunophenotype and more recently, genotype, began with the Kiel, and Lukes and Collins classifications in the late 1970s, becoming fully expressed in the REAL and subsequently WHO classifications. The current, multidisciplinary approach to categorisation adds significantly to the task facing the anatomical pathologist, since it requires distribution of biopsy material to all the appropriate specialised laboratories, the gathering of a range of cross-disciplinary information, the correlation of all diagnostic findings, deduction of a definitive diagnosis and, finally, integration of all the above into a single multi-parameter report. In this review, we summarise the contemporary approach to the biopsy, diagnosis and reporting of lymphoproliferative disorders.

Original languageEnglish
Pages (from-to)434-456
Number of pages23
Issue number6
Publication statusPublished - Dec 2005
Externally publishedYes


  • Biopsy
  • Diagnosis
  • Hodgkin lymphoma
  • Humans
  • Immunohistochemistry
  • Immunology
  • Lymph nodes
  • Lymphoma
  • Pathology
  • Test performance

Fingerprint Dive into the research topics of 'Diagnostic pathology of lymphoproliterative disorders'. Together they form a unique fingerprint.

Cite this